These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


420 related items for PubMed ID: 28083702

  • 1. Increased urinary neutrophil gelatinase-associated lipocalin in very-low-birth-weight infants with oliguria and normal serum creatinine.
    Shin SY, Ha JY, Lee SL, Lee WM, Park JH.
    Pediatr Nephrol; 2017 Jun; 32(6):1059-1065. PubMed ID: 28083702
    [Abstract] [Full Text] [Related]

  • 2. Serum Cystatin C as an Early Marker of Neutrophil Gelatinase-associated Lipocalin-positive Acute Kidney Injury Resulting from Cardiopulmonary Bypass in Infants with Congenital Heart Disease.
    Herbert C, Patel M, Nugent A, Dimas VV, Guleserian KJ, Quigley R, Modem V.
    Congenit Heart Dis; 2015 Jun; 10(4):E180-8. PubMed ID: 25727405
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prediction of urine volume soon after birth using serum cystatin C.
    Kasamatsu A, Ohashi A, Tsuji S, Okada H, Kanzaki H, Kaneko K.
    Clin Exp Nephrol; 2016 Oct; 20(5):764-769. PubMed ID: 26711242
    [Abstract] [Full Text] [Related]

  • 5. Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria.
    Legrand M, Jacquemod A, Gayat E, Collet C, Giraudeaux V, Launay JM, Payen D.
    Intensive Care Med; 2015 Jan; 41(1):68-76. PubMed ID: 25465906
    [Abstract] [Full Text] [Related]

  • 6. Reference intervals of serum cystatin C/creatinine ratio of 30 postnatal days in neonates.
    Hahn WH, Bae CW.
    Pediatr Nephrol; 2014 Feb; 29(2):311-4. PubMed ID: 24114579
    [Abstract] [Full Text] [Related]

  • 7. Renal markers cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) in postmortem samples.
    Keltanen T, Walta AM, Salonen S, Sajantila A, Lindroos K.
    Forensic Sci Med Pathol; 2016 Jun; 12(2):189-92. PubMed ID: 26972903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies].
    Proletov IaIu, Saganova ES, Galkina OV, Zubina IM, Bogdanova EO, Sipovskiĭ VG, Smirnov AV.
    Ter Arkh; 2013 Jun; 85(6):10-6. PubMed ID: 23866593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C.
    Am J Cardiol; 2015 Jul 01; 116(1):104-11. PubMed ID: 25943992
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy.
    Stypmann J, Fobker M, Rosing K, Engelen M, Gunia S, Dell'Aquila AM, Nofer JR.
    J Cardiol; 2015 Oct 01; 66(4):347-52. PubMed ID: 25583090
    [Abstract] [Full Text] [Related]

  • 19. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery.
    Seitz S, Rauh M, Gloeckler M, Cesnjevar R, Dittrich S, Koch AM.
    Swiss Med Wkly; 2013 Oct 01; 143():w13744. PubMed ID: 23348800
    [Abstract] [Full Text] [Related]

  • 20. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study).
    Brankovic M, Akkerhuis KM, Buljubasic N, Cheng JM, Oemrawsingh RM, Garcia-Garcia HM, Regar E, Serruys PW, van Geuns RJ, Boersma E, Kardys I.
    Atherosclerosis; 2016 Nov 01; 254():20-27. PubMed ID: 27680774
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.